The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
11C-acetate PET imaging in prostate cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
Bubley, G. J., Carducci, M., Dahut, W., Dawson, N., Daliani, D., Eisenberger, M., Figg, W. D., Freidlin, B., Halabi, S., Hudes, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3461 · Cited by 977
Self-citationThe applications of PET in clinical oncology.
Strauss, L. G., & Conti, P. S. (1991) · PubMed · Cited by 844
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
Rigo, P., Paulus, P., Kaschten, B. J., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01249629 · Cited by 501
TNM Classification of Malignant Tumors.5th ed
Szucs, R. (1998) · Radiology · doi:10.1148/radiology.207.1.66 · Cited by 448
Prediction of survival in glioma patients by means of positron emission tomography
Patronas, N. J., Chiro, G. D., Kufta, C., Bairamian, D., Kornblith, P. L., Simon, R., & Larson, S. M. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.62.6.0816 · Cited by 405
Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., & Verhoeven, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10127 · Cited by 381
PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER
MOUL, J. W. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67511-8 · Cited by 350
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
Glucose utilizationin vivo by human pulmonary neoplasms
Nolop, K. B., Rhodes, C. G., Brudin, L. H., Beaney, R. P., Krausz, T., Jones, T., & Hughes, J. M. B. (1987) · Cancer · doi:10.1002/1097-0142(19871201)60:11<2682::aid-cncr2820601118>3.0.co;2-h · Cited by 261
Yoshimoto, M., Waki, A., Yonekura, Y., Sadato, N., Murata, T., Omata, N., Takahashi, N., Welch, M. J., & Fujibayashi, Y. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00195-5 · Cited by 236
Clinical states in prostate cancer: toward a dynamic model of disease progression
Scher, H. I., & Heller, G. (2000) · Urology · doi:10.1016/s0090-4295(99)00471-9 · Cited by 232
Self-citationFDG uptake, tumour characteristics and response to therapy: A review
SMITH, T. A. D. (1998) · Nuclear Medicine Communications · doi:10.1097/00006231-199802000-00002 · Cited by 200
Scher, H. I., Eisenberger, M., D'Amico, A. V., Halabi, S., Small, E. J., Morris, M., Kattan, M. W., Roach, M., Kantoff, P., Pienta, K. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.099 · Cited by 200
Self-citationSeltzer, M., Barbaric, Z. L., Belldegrun, A. S., Naitoh, J., Dorey, F. J., Phelps, M. E., Gambhir, S. S., & Hoh, C. K. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68277-8 · Cited by 186
The Increased Accumulation of [18F]Fluorodeoxyglucose in Untreated Prostate Cancer
Oyama, N., Akino, H., Suzuki, Y., Kanamaru, H., Sadato, N., Yonekura, Y., & Okada, K. (1999) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/29.12.623 · Cited by 152
Facilitative glucose transporter expression in human cancer tissue.
Smith, T. (1999) · PubMed · Cited by 124
Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo
Heemers, H. V., Vanderhoydonc, F., Roskams, T., Shechter, I., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00205-3 · Cited by 82
Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem
Kato, T., Fukatsu, H., Ito, K., Tadokoro, M., Ota, T., Ikeda, M., Isomura, T., Ito, S., Nishino, M., & Ishigaki, T. (1995) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00997245 · Cited by 68
Cited by
Clinical Applications of PET in Oncology
Rohren, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 859
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820
“Acetate-based PET tracers are established clinical tools, but to date there is not enough information on how this tracer reflects perturbations in lipid biosynthesis in cancer cells (Lewis et al., 2014; Oyama et al., 2002; Yun et al., 2009).”
BackgroundAcetate is a bioenergetic substrate for human glioblastoma and brain metastases
Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K. J., Singh, D. K., Sirasanagandla, S., Nannepaga, S., Piccirillo, S. G., Kovacs, Z., Foong, C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.025 · Cited by 760
Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., Walters, H., Tantawy, M. N., Fu, A., Manning, H. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.020 · Cited by 681
Overview of image-guided radiation therapy
Xing, L., Thorndyke, B., Schreibmann, E., Yang, Y., Li, T.-F., Kim, G.-Y., Luxton, G., & Koong, A. (2006) · Medical Dosimetry · doi:10.1016/j.meddos.2005.12.004 · Cited by 468
Metadata
- Authors
- Morris, M. J., & Scher, H. I.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2006-11-25
- Volume
- 34
- Issue
- 2
- Pages
- 181-184
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W1991978562
- Cited by
- 294
- References
- 21
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.